SCHEMBL6935345

SCHEMBL6935345

Cc1cccc(NC(=O)c2cnc(N)nc2)c1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.70
KMT2A Q03164 5/20 0.70
SMN1; SMN2 Q16637 3/20 0.70
ALDH1A1 P00352 2/20 0.70
LMNA P02545 1/20 0.70
RXFP1 Q9HBX9 1/20 0.65
KCNK3 O14649 6/20 0.60
KCNK9 Q9NPC2 6/20 0.60
KCNH2 Q12809 1/20 0.60
POLB P06746 1/20 0.56
RAB9A P51151 2/20 0.56
NPC1 O15118 1/20 0.56
TP53 P04637 1/20 0.56
NFKB1 P19838 1/20 0.56
NFKB2 Q00653 1/20 0.56
RELA Q04206 1/20 0.56
GAA P10253 1/20 0.55
CSF1R P07333 1/20 0.55
KIT P10721 1/20 0.55
THRB P10828 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL259364 0.86 MEN1 (0.75) MEN1KMT2ASMN1; SMN2ALDH1A1LMNA
SCHEMBL21349104 0.83 KMT2A (0.67) MEN1KMT2ASMN1; SMN2ALDH1A1LMNA
SCHEMBL4560198 0.81 KDM4E (0.65) ALDH1A1RAB9ANPC1HTTKDM4E
SCHEMBL2908619 0.81 MEN1 (0.89) MEN1KMT2ASMN1; SMN2ALDH1A1LMNA
SCHEMBL682877 0.80 MEN1 (0.71) MEN1KMT2ASMN1; SMN2ALDH1A1LMNA
SCHEMBL259296 0.80 KMT2A (0.80) MEN1KMT2ASMN1; SMN2ALDH1A1LMNA
SCHEMBL14308003 0.80 MEN1 (0.66) MEN1KMT2ASMN1; SMN2ALDH1A1LMNA
SCHEMBL4253897 0.79 KCNK3 (0.93) MEN1KMT2ARXFP1KCNK3KCNK9
SCHEMBL23367927 0.79 KMT2A (0.69) MEN1KMT2ASMN1; SMN2ALDH1A1LMNA
SCHEMBL21620291 0.79 KMT2A (0.69) MEN1KMT2ASMN1; SMN2ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011114275-A1 SPIROCYCLIC COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS AND DIAGNOSTIC PROBES UNIVERSITY OF BASEL (CH) 2011-09-22 WO disclosed